2022 annual financial data
Solid Biosciences 2022 Revenue growth
Direct answer
Revenue growth was -40.57%.
Operating income was -106,452,000 USD and net income was -85,981,000 USD.
Operating cash flow was -97,977,000 USD.
Get free Solid Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 8,094,000 USD
- Operating income
- -106,452,000 USD
- Net income
- -85,981,000 USD
- Operating cash flow
- -97,977,000 USD